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Background: According to the guidelines, aortic valve replacement (AVR) is class I recommendation for severe AS patients with symptoms and/
or left ventricular (LV) dysfunction. However, it has been reported that many patients with class I recommendation don’t undergo AVR in the western 
countries. There have been no reports about actual managements of patients with severe AS in Japanese population. The purpose of this study is to 
ascertain the actual management of severe AS in our country, and the impact of management on patients’ prognosis.
Methods: We retrospectively investigated management and prognosis in 373 consecutive patients (128 males, median age; 75years) who were 
diagnosed as severe AS (valve area<1.0cm2) without other valvular heart disease between 1999 and 2009. Primary end-point was defined as the 
composite of cardiac death during follow-up and operative mortality within 30 days after AVR.
Results: Among 373 patients, 227 patients (61 %) had symptoms and/or LV dysfunction (EF<50%). Among these 227 patients, 166 patients 
underwent AVR according to the guidelines, but 61 patients didn’t (group X). The reasons for not operating were prohibited comorbidities in 
39 patients, advanced age in 23 patients and patient refusal in 34 patients. On the other hand, among 146 asymptomatic patients without LV 
dysfunction, 97 patients were followed-up medically according to guidelines, but 49 patients underwent AVR (group E). Thus, management was 
determined according to guidelines in 263 patients (71%) (Group G). Group X showed extremely poor prognosis compared with group E and group G 
(5 year-cardiac death free rate: 47%, p<0.00001). Group E showed better prognosis than group G (7 year-cardiac death free rate: 92% vs 82%), but 
it is not statistically significant.
Conclusions: The present study demonstrated that management was determined according to the guidelines in 71% of the patients with severe 
AS. Early operation was performed in 34% of the asymptomatic severe AS patients with normal LV function, and they showed good long-term 
prognosis.
